ES2136082T3 - El proto-oncogen met como receptor del factor de crecimiento hepatico. - Google Patents
El proto-oncogen met como receptor del factor de crecimiento hepatico.Info
- Publication number
- ES2136082T3 ES2136082T3 ES92905178T ES92905178T ES2136082T3 ES 2136082 T3 ES2136082 T3 ES 2136082T3 ES 92905178 T ES92905178 T ES 92905178T ES 92905178 T ES92905178 T ES 92905178T ES 2136082 T3 ES2136082 T3 ES 2136082T3
- Authority
- ES
- Spain
- Prior art keywords
- receptor
- growth factor
- proto
- met
- oncogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/642,971 US5648273A (en) | 1989-12-27 | 1991-01-18 | Hepatic growth factor receptor is the MET proto-oncogene |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2136082T3 true ES2136082T3 (es) | 1999-11-16 |
Family
ID=24578815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92905178T Expired - Lifetime ES2136082T3 (es) | 1991-01-18 | 1992-01-15 | El proto-oncogen met como receptor del factor de crecimiento hepatico. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5648273A (ja) |
EP (1) | EP0567585B1 (ja) |
JP (2) | JP2598362B2 (ja) |
AT (1) | ATE182902T1 (ja) |
AU (1) | AU652031B2 (ja) |
CA (2) | CA2099865C (ja) |
DE (1) | DE69229720T2 (ja) |
DK (1) | DK0567585T3 (ja) |
ES (1) | ES2136082T3 (ja) |
GR (1) | GR3031381T3 (ja) |
WO (1) | WO1992013097A1 (ja) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5871959A (en) * | 1989-12-27 | 1999-02-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of producing hepatocycte growth factor/scatter factor and related cell lines |
US5362716A (en) * | 1989-12-27 | 1994-11-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines |
EP0584125B1 (en) * | 1991-05-10 | 1997-07-16 | PHARMACIA & UPJOHN S.p.A. | Truncated forms of the hepatocyte growth factor (hgf) receptor |
AU675968B2 (en) * | 1992-09-18 | 1997-02-27 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services | A method of preventing tumor metastasis |
US6214344B1 (en) | 1995-06-02 | 2001-04-10 | Genetech, Inc. | Hepatocyte growth factor receptor antagonists and uses thereof |
US5686292A (en) * | 1995-06-02 | 1997-11-11 | Genentech, Inc. | Hepatocyte growth factor receptor antagonist antibodies and uses thereof |
US5646036A (en) * | 1995-06-02 | 1997-07-08 | Genentech, Inc. | Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies |
US5855918A (en) * | 1995-09-12 | 1999-01-05 | Genentech, Inc. | Cystic fibrosis therapy |
US5866329A (en) * | 1995-09-27 | 1999-02-02 | Demetriou; Achilles A. | Method and probe for detection of gene associated with liver neoplastic disease |
AU7254896A (en) * | 1995-10-05 | 1997-04-28 | Genentech Inc. | Improved angiogenesis using hepatocyte growth factor |
WO1997012628A1 (en) * | 1995-10-05 | 1997-04-10 | Genentech, Inc. | Methods and compositions for treating vascular stenosis |
DK0922102T3 (da) * | 1996-07-03 | 2010-08-16 | Genentech Inc | Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf |
JP4006058B2 (ja) * | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び/又は治療剤 |
WO1998041230A1 (fr) | 1997-03-14 | 1998-09-24 | Snow Brand Milk Products Co., Ltd. | Agent preventif et/ou curatif de la cachexie |
EP1840575A1 (en) | 2000-08-28 | 2007-10-03 | Damavand Wound AB | Kit for determining HGF |
US20030118585A1 (en) * | 2001-10-17 | 2003-06-26 | Agy Therapeutics | Use of protein biomolecular targets in the treatment and visualization of brain tumors |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
HN2004000285A (es) | 2003-08-04 | 2006-04-27 | Pfizer Prod Inc | ANTICUERPOS DIRIGIDOS A c-MET |
ES2321105T3 (es) * | 2003-09-29 | 2009-06-02 | Peas Institut Ab | Determinacion rapida de formas diferentes del factor de crecimiento de hepatocitos (hgf) en los fluidos corporales. |
EP1697415A1 (en) | 2003-11-12 | 2006-09-06 | Biogen Idec MA Inc. | NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
PL1773885T3 (pl) | 2004-08-05 | 2010-09-30 | Genentech Inc | Humanizowani antagoniści anty c-met |
SG173313A1 (en) | 2005-01-05 | 2011-08-29 | Biogen Idec Inc | Cripto binding molecules |
TWI362940B (en) | 2005-03-31 | 2012-05-01 | Gen Hospital Corp | A use of agonist and/or antagonist of hgf/hgfr activity |
SG161281A1 (en) | 2005-04-15 | 2010-05-27 | Genentech Inc | Hgf beta chain variants |
WO2007049620A1 (ja) * | 2005-10-24 | 2007-05-03 | Fujifilm Ri Pharma Co., Ltd. | 肝細胞増殖因子受容体が関与する疾患の診断薬及び治療薬 |
EP1957541A2 (en) * | 2005-11-21 | 2008-08-20 | Laboratoires Serono SA | Compositions and methods of producing hybrid antigen binding molecules and uses thereof |
KR101671378B1 (ko) * | 2009-10-30 | 2016-11-01 | 삼성전자 주식회사 | c-Met에 특이적으로 결합하는 항체 및 그의 용도 |
KR102059663B1 (ko) | 2010-03-10 | 2019-12-26 | 젠맵 에이/에스 | C―met에 대한 모노클로날 항체 |
KR20140002601A (ko) | 2010-07-09 | 2014-01-08 | 바이오겐 이데크 헤모필리아 인코포레이티드 | 키메라 응고 인자 |
EP3165538A1 (en) | 2010-11-03 | 2017-05-10 | Argen-X Nv | Anti c-met antibodies |
AR086823A1 (es) | 2011-06-30 | 2014-01-22 | Genentech Inc | Formulaciones de anticuerpo anti-c-met, metodos |
WO2013012733A1 (en) | 2011-07-15 | 2013-01-24 | Biogen Idec Ma Inc. | Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto |
EP2773660A2 (en) | 2011-11-03 | 2014-09-10 | Argen-X B.V. | Chimeric human-camel antigens and their use |
AU2013207927B2 (en) | 2012-01-10 | 2017-11-02 | Biogen Ma Inc. | Enhancement of transport of therapeutic molecules across the blood brain barrier |
UY35463A (es) | 2013-03-15 | 2014-10-31 | Biogen Idec Inc | Formulaciones de polipéptido fc-factor ix. |
MA39776A (fr) | 2014-03-24 | 2017-02-01 | Hoffmann La Roche | Traitement du cancer avec des antagonistes de c-met et corrélation de ces derniers avec l'expression de hgf |
CN107636159B (zh) | 2015-02-04 | 2022-06-14 | 百时美施贵宝公司 | 选择治疗性分子的方法 |
EP3253875B1 (en) | 2015-02-04 | 2020-01-08 | H. Hoffnabb-La Roche Ag | Tau antisense oligomers and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5030565A (en) * | 1983-08-17 | 1991-07-09 | Scripps Clinic And Research Foundation | Polypeptide-induced monoclonal receptors to protein ligands |
-
1991
- 1991-01-18 US US07/642,971 patent/US5648273A/en not_active Expired - Lifetime
-
1992
- 1992-01-15 AU AU12738/92A patent/AU652031B2/en not_active Expired
- 1992-01-15 EP EP92905178A patent/EP0567585B1/en not_active Expired - Lifetime
- 1992-01-15 WO PCT/US1992/000071 patent/WO1992013097A1/en active IP Right Grant
- 1992-01-15 CA CA002099865A patent/CA2099865C/en not_active Expired - Lifetime
- 1992-01-15 CA CA002176620A patent/CA2176620C/en not_active Expired - Lifetime
- 1992-01-15 ES ES92905178T patent/ES2136082T3/es not_active Expired - Lifetime
- 1992-01-15 JP JP4505290A patent/JP2598362B2/ja not_active Expired - Lifetime
- 1992-01-15 AT AT92905178T patent/ATE182902T1/de not_active IP Right Cessation
- 1992-01-15 DK DK92905178T patent/DK0567585T3/da active
- 1992-01-15 DE DE69229720T patent/DE69229720T2/de not_active Expired - Lifetime
-
1996
- 1996-07-18 JP JP20772896A patent/JP3387745B2/ja not_active Expired - Lifetime
-
1999
- 1999-09-29 GR GR990402475T patent/GR3031381T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5648273A (en) | 1997-07-15 |
EP0567585B1 (en) | 1999-08-04 |
DK0567585T3 (da) | 1999-12-13 |
JP3387745B2 (ja) | 2003-03-17 |
CA2099865C (en) | 1997-11-25 |
AU652031B2 (en) | 1994-08-11 |
EP0567585A1 (en) | 1993-11-03 |
CA2176620A1 (en) | 1992-07-19 |
EP0567585A4 (ja) | 1994-08-03 |
GR3031381T3 (en) | 2000-01-31 |
DE69229720D1 (de) | 1999-09-09 |
ATE182902T1 (de) | 1999-08-15 |
JP2598362B2 (ja) | 1997-04-09 |
CA2099865A1 (en) | 1992-07-19 |
WO1992013097A1 (en) | 1992-08-06 |
JPH09127107A (ja) | 1997-05-16 |
DE69229720T2 (de) | 2000-04-27 |
JPH06505968A (ja) | 1994-07-07 |
CA2176620C (en) | 2001-04-24 |
AU1273892A (en) | 1992-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2136082T3 (es) | El proto-oncogen met como receptor del factor de crecimiento hepatico. | |
NL7801372A (nl) | Nieuwe fysiologisch werkzame verbinding en werkwijze voor het bereiden daarvan langs microbiologische weg, alsmede farmaceutische preparaten met immunosuppressieve werking die de verbinding bevatten. | |
IT1063138B (it) | Cannula,particolarmente per angio grafia | |
ES2089316T3 (es) | Agente viral asociado con la enfermedad porcina misteriosa (mystery swine desease). | |
FI872756A0 (fi) | Med laserstraolning fungerande terapeutisk anordning. | |
NL7607637A (nl) | Werkwijze voor het bereiden van 2'.4-dichloor 4'-benzoylureidodifenylethers, alsmede de toe- passing daarvan als insecticiden. | |
NL930112I2 (nl) | Benzazepine-2-onen, werkwijzen ter bereiding daarvan, farmaceutische preparaten die deze verbindingen bevatten, alsmede de verbindingen voor de therapeutische toepassing. | |
ZA877859B (en) | 5-nitrobenzo(de)isoquinoline-1.3-diones,their preparation and their use | |
ATE87484T1 (de) | Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
OA05223A (fr) | Dérivés de l'alcoyloxy-5 phényl-3 oxadiazoline-1,3,4 one-2, leur préparation et les compositions insecticides et acaricides qui les contiennent. | |
FR2346332A1 (fr) | Nouveaux derives de prostaglandine, leur procede de preparation ainsi que les compositions therapeutiques les contenant | |
MD940152A (ro) | Compoziţie farmaceutică pentru tratarea infecţiilor şi bolilor, provocate de virusul hepatitei V (HBV) | |
FR2397385A1 (fr) | Derives du resorcinol, leur preparation et leurs utilisations therapeutiques | |
NO901631D0 (no) | Fremgangsmaate for fremstilling av 2-substituerte n,n'-ditrimetoksybenzoyl-piperaziner. | |
ES513974A0 (es) | Procedimiento de preparacion de derivados del 3,4-difenil-5-metil pirazol. | |
IT1141183B (it) | Incastellatura tubolare per palchi,banchi,scaffalature,armadi o simili | |
NO144411C (no) | Anordning for gradering av biologisk vaeslke, saerlig blod, etter molekylvekt. | |
SE8402327L (sv) | Anordning for att underletta forflyttning av stolar | |
IT8026232A0 (it) | Composizioni farmaceutiche. derivato dell'alfa-mercapto propionilglicina ad attivita'terapeutica, procedimento per lasua preparazione e relative | |
ATE32027T1 (de) | Pflegebett. | |
FR2304340A1 (fr) | Nouveaux derives de prostaglandine, leur procede de preparation ainsi que les compositions therapeutiques les contenant | |
NL171585C (nl) | Werkwijze voor de bereiding van farmaceutische preparaten met werking op het centrale zenuwstelsel op basis van 6-fenyl-1-oxoimidazo-1,2-abenzof-1,4-diazepinen en werkwijze voor de bereiding van deze verbindingen. | |
NL186006C (nl) | Verbindingen en farmaceutische preparaten met een anticholinergische, anti-histaminische, hoeststillende en/of analgetische werking, en werkwijze voor de bereiding van de verbindingen. | |
GB1403342A (en) | Sportswear | |
IT7820190A0 (it) | Composti carbonilici, procedimento per la loro preparazione e loro impiego. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 567585 Country of ref document: ES |